Myelin proteolipid protein: Function in myelin structure is distinct from its role in oligodendrocyte development

Developmental Neuroscience

Volumn 20, Issue 6, 1998, Pages 533-539

  Nadon, Nancy L ^a,b   West, Melinda ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

DM20; Dysmyelination; Rumpshaker; Transgenic mice

Indexed keywords

MYELIN; PROTEOLIPID PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TRANSPORT; TRANSGENE; WHITE MATTER;

ANIMALS; BIOLOGICAL TRANSPORT; CELL AGING; CENTRAL NERVOUS SYSTEM; MICE; MICE, TRANSGENIC; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; OLIGODENDROGLIA; STAINING AND LABELING;

EID: 0032434023     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017354     Document Type: Article

References (34)

1. Nave K-A, Lai C, Bloom FE, Milner RJ (1987): Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci USA 84:5665-5669.
2. Duncan ID (1987): Abnormalities of myelination of the central nervous system associated with congenital tremor. J Vet Int Med 1:10-23.
3. Duncan ID, Hammang JP, Goda S, Quarles RH (1989): Myelination in the jimpy mouse in the absence of proteolipid protein. Glia 2:148-154.
4. Boison D, Stoffel W (1994): Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci USA 91:11709-11713.
5. Klugmann M, Schwab M, Puhlhofer A, Schneider A, Zimmermann F, Griffiths I, Nave K (1997): Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70.
6. Nadon NL, Duncan ID, Hudson LD (1990): A point mutation in the proteolipid protein gene of the shaking pup interrupts oligodendrocyte development. Development 110:529-537.
7. Nadon NL, Duncan ID (1995): Gene expression and oligodendrocyte development in the myelin deficient rat. J Neurosci Res 41:96-104.
8. Nadon N, Duncan ID (1996): Molecular analysis of glial cell development in the canine 'Shaking Pup' mutant. Dev Neurosci 18:174-184.
9. Hudson LD, Nadon NL (1992): Amino acid substitutions in proteolipid protein that cause dysmyelination; in Martenson RE (ed): Myelin: Biology and Chemistry. New Jersey, Telford, pp 677-702.
10. Duncan ID (1995): Inherited disorders of myelination of the central nervous system; in Kettenmann H, Ransom BR (eds): Neuroglia. New York, Oxford University Press, pp 990-1009.
11. Nave K-A (1995): Neurological mouse mutants: A molecular genetic analysis of myelin proteins; in Kettenmann H, Ransom BR (eds): Neuroglia. New York, Oxford University Press, pp 571-586.
12. Nadon NL, Arnheiter H, Hudson LD (1994): A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse. J Neurochem 63:822-833.
13. Schneider A, Griffiths IR, Readhead C, Nave K-A (1995): Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc Natl Acad Sci USA 92:4447-4451.
14. Bartlett WP, Knapp PE, Skoff RP (1988): Glial conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: Production of myelin antigens and membranes. Glia 1:253-259.
15. Roussel G, Neskovic NM, Trifilieff E, Artault J-C, Nussbaum J-L (1987): Arrest of proteolipid transport through the Golgi apparatus in jimpy brain. J Neurocytol 16:195-204.
16. Timsit S, Sinoway MP, Levy L, Allinquant B, Stempak J, Staugaitis SM, Colman DR (1992): The DM20 protein of myelin: Intracellular and surface expression of patterns in transfectants. J Neurochem 58:1936-1942.
17. Sinoway MP, Kitagawa K, Timsit S, Hashim GA, Colman DR (1994): Proteolipid protein interactions in transfectants: Implications for myelin assembly. J Neurosci Res 37:551-562.
18. Gow A, Friedrich VL, Lazzarini RA (1994): Intracellular transport and sorting of the oligodendrocyte transmembrane proteolipid protein. J Neurosci Res 37:563-573.
19. Thomson CE, Montague P, Jung M, Nave K-A, Griffiths IR (1997): Phenotypic severity of murine plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins. Glia 20:322-332.
20. Gow A, Friedrich VL, Lazzarini RA (1994): Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J Neurosci Res 37:574-583.
21. Gow A, Lazzarini R (1996): A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet 13:422-428.
22. Schneider A, Montague P, Griffiths I, Fanarraga M, Kennedy P, Brophy P, Nave K-A (1992): Uncoupling of hypomyelination and glial cell death by mutation in the proteolipid protein gene. Nature 358:758-761.
23. Nadon NL, Draeger K (1996): Genomic DNA analysis from mouse toe lysates. Transgenic Res 5:1-3.
24. Griffiths IR, Scott I, McCulloch C, Barrie JA, McPhilemy K, Cattanach BM (1990): Rump-shaker mouse: A new X-linked mutation affecting myelination: Evidence for a defect in PLP expression. J Neurocytol 19:273-283.
25. Hudson LD, Friedrich VL, Behar T, Dubois-Dalcq M, Lazzarini RA (1989): The initial events in myelin synthesis: Orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes. J Cell Biol 109:717-727.
26. Nadon NL, Miller S, Draeger K, Salvaggio M (1997): Myelin proteolipid DM20: Evidence for function independent of myelination. Int J Dev Neurosci 15:285-293.
27. Hudson LD, Puckett C, Berndt J, Chan J, Gencic S (1989): Mutation of the proteolipid protein (PLP) gene in a human X-linked myelin disorder. Proc Natl Acad Sci USA 86:8128-8131.
28. Hasel KW, Stucliffe JG (1990): Nucleotide sequence of a cDNA coding for mouse cyclophilin. Nucleic Acids Res 18:4019.
29. Fanarraga MI, Griffiths IR, McCullough MC, Barrie JA, Kennedy PGE, Brophy PJ (1992): Rumpshaker: An X-linked mutation causing hypomyelination: Developmental differences in myelination and glial cells between the optic nerve and spinal cord. Glia 5:161-170.
30. Skoff R, Knapp P (1992): Phenotypic expression of X-linked genetic defects; in Martenson RE (ed): Myelin: Biology and Chemistry. New Jersey, Telford, pp 653-676.
31. Jung M, Sommer I, Schachner M, Nave K (1996): Monoclonal antibody 010 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): Evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16:7920-7929.
32. Ikenaka K, Kagawa T, Mikoshiba K (1992): Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and nonglial cells. J Neurochem 58:2248-2253.
33. Timsit SG, Bally-Cuif L, Colman DR, Zalc B (1992): DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse. J Neurochem 58:1172-1175.
34. Dickinson P, Fanarraga M, Griffiths I, Barrie J, Kyriakides E, Montague P (1996): Oligodendrocyte progenitors in the embryonic spinal cord express DM-20. Neuropathol Appl Neurobiol 22:188-198.